NM_000284.4:c.1132C>T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PM5PP3PP4PM6_Strong
This summary comes from the ClinGen Evidence Repository: The c.1132C>T (p.R378C) variant in PDHA1 has been reported in multiples males and females with pyruvate dehydrogenase deficiency and is one of the more common pathogenic variants seen in this cohort (PMID:22896851). It has been seen in at least three individuals with decreased pyruvate dehydrogenase activity (PP4; Patient 6 in PMID:8962591; Subject M-7 in PMID:20002461; Subject 35-2 in PMID:10679936). This variant has been identified as a de novo occurrence (unconfirmed parental relationships) in at least 4 unrelated individuals with pyruvate dehydrogenase deficiency [PM6_Strong; utilized ClinGen SVI de novo scoring guidance (phenotype consistent but not highly specific); PMID:10679936, subject 35-2; PMID:20002461, subject M-7; PMID:21914562, subject AM8; PMID:21914562, subject AF22]. Of note, to our knowledge, there are no reports of this variant being inherited from a healthy mother, however it is important to note that not all cases reported in the literature had mothers who were tested. This variant is absent from gnomAD v2.1.1 (PM2). Another missense variant at this position [c.1133G>A, p.R378H] has been reported in at least six other probands (PM5; PMIDs: 8032855 - 1 case, 7887409 - 2 cases, 9409363 - 3 cases) and is a known pathogenic variant. The computational predictor REVEL gives a score of 0.907, which is above the threshold of 0.75, evidence that correlates with impact to PDHA1 function (PP3). In summary, this variant meets criteria to be classified as pathogenic for pyruvate dehydrogenase deficiency inherited in an X-linked manner. This classification was approved by the NICHD U24 Mitochondrial Disease Variant Curation Expert Panel on May 20, 2020. PDHA1-specific ACMG/AMP criteria applied: PM2, PM5, PM6_strong, PP3, PP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA323094/MONDO:0019169/014
Frequency
Consequence
NM_000284.4 missense
Scores
Clinical Significance
Conservation
Publications
- Leigh syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- pyruvate dehydrogenase E1-alpha deficiencyInheritance: XL, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
- Leigh syndrome with leukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000284.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PDHA1 | NM_000284.4 | MANE Select | c.1132C>T | p.Arg378Cys | missense | Exon 11 of 11 | NP_000275.1 | ||
| PDHA1 | NM_001173454.2 | c.1246C>T | p.Arg416Cys | missense | Exon 12 of 12 | NP_001166925.1 | |||
| PDHA1 | NM_001173455.2 | c.1153C>T | p.Arg385Cys | missense | Exon 11 of 11 | NP_001166926.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PDHA1 | ENST00000422285.7 | TSL:1 MANE Select | c.1132C>T | p.Arg378Cys | missense | Exon 11 of 11 | ENSP00000394382.2 | ||
| PDHA1 | ENST00000947567.1 | c.1330C>T | p.Arg444Cys | missense | Exon 13 of 13 | ENSP00000617626.1 | |||
| PDHA1 | ENST00000947577.1 | c.1291C>T | p.Arg431Cys | missense | Exon 12 of 12 | ENSP00000617636.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 22
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at